TriSalus Life Sciences Stock (NASDAQ: TLSI) stock price, news, charts, stock research, profile.
Open | $5.69 |
Close | $5.52 |
Volume / Avg. | 45.74K / 41.81K |
Day Range | 5.52 - 5.69 |
52 Wk Range | 3.32 - 16.24 |
Market Cap | $151.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 3.19% |
Days to Cover | 12.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TriSalus Life Sciences (NASDAQ:TLSI) through any online brokerage.
Other companies in TriSalus Life Sciences’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).
There is no analysis for TriSalus Life Sciences.
TriSalus Life Sciences has a consensus price target of $14.00.
The stock price for TriSalus Life Sciences (NASDAQ: TLSI) is $5.52 last updated June 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for TriSalus Life Sciences.
TriSalus Life Sciences’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for TriSalus Life Sciences.
TriSalus Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.